| pubmed-article:20050100 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20050100 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20050100 | lifeskim:mentions | umls-concept:C0034380 | lld:lifeskim |
| pubmed-article:20050100 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:20050100 | lifeskim:mentions | umls-concept:C0068475 | lld:lifeskim |
| pubmed-article:20050100 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:20050100 | pubmed:dateCreated | 2009-12-10 | lld:pubmed |
| pubmed-article:20050100 | pubmed:abstractText | Nebivolol is a highly selective beta-adrenoreceptor antagonist with vasodilating properties. This study investigated its effect on quality of life (QoL) and blood pressure (BP) in real life conditions. In total, 1468 patients were enrolled, 12% diabetics. Nebivolol was prescribed as monotherapy, add-on or switch medication. | lld:pubmed |
| pubmed-article:20050100 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20050100 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20050100 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20050100 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20050100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20050100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20050100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20050100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20050100 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20050100 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20050100 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:20050100 | pubmed:issn | 0803-8023 | lld:pubmed |
| pubmed-article:20050100 | pubmed:author | pubmed-author:AlbertAdelinA | lld:pubmed |
| pubmed-article:20050100 | pubmed:author | pubmed-author:SeidelLaurenc... | lld:pubmed |
| pubmed-article:20050100 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:20050100 | pubmed:author | pubmed-author:HermansMichel... | lld:pubmed |
| pubmed-article:20050100 | pubmed:author | pubmed-author:Van de... | lld:pubmed |
| pubmed-article:20050100 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20050100 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:20050100 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20050100 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20050100 | pubmed:pagination | 5-14 | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:meshHeading | pubmed-meshheading:20050100... | lld:pubmed |
| pubmed-article:20050100 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20050100 | pubmed:articleTitle | Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study. | lld:pubmed |
| pubmed-article:20050100 | pubmed:affiliation | Department of endocrinology and Nutrition, St-Luc University Hospital, Catholic University of Louvain, Brussels, Belgium. michel.hermans@diab.ucl.ac.be | lld:pubmed |
| pubmed-article:20050100 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20050100 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:20050100 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20050100 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20050100 | lld:pubmed |
